NEWS

Stay updated with the latest news, announcements, and insights.

October 6, 2021 Press Release

PanTher Therapeutics Doses First Two Patients in Phase 1 Trial of PTM-101 for Treatment of Pancreatic Cancer

June 17, 2021 Press Release

PanTher Therapeutics Closes Oversubscribed $5.4M Series A Round, Expands Board of Directors, As Company Prepares to Initiate First Clinical Trial of Novel Localized Treatment of Pancreatic Cancer

October 16, 2018 Press Release

PanTher Therapeutics Announces Agreement with MD Anderson Cancer Center and Appointment of Senior Clinical Advisor

December 8, 2015 News

PanTher Therapeutics’ CEO, Dr. Laura Indolfi, Named a TED Fellow